[RGLS] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
09-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 13.25%
YoY- 72.98%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 302 0 0 5,000 18 18 18 59.96%
PBT -8,061 -6,795 -7,133 -1,315 -4,893 -8,502 -14,506 -9.32%
Tax 100 1 214 7 -131 61 -58 -
NP -8,061 -6,796 -7,133 -1,322 -4,893 -8,563 -14,448 -9.26%
Tax Rate - - - - - - - -
Total Cost 8,363 6,796 7,133 6,322 4,911 8,581 14,466 -8.72%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -2,669.21 0.00 0.00 -26.44 -27,183.33 -47,572.22 -80,266.67 -43.27%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.40 -0.40 -0.67 -0.28 -2.34 -9.75 -16.68 -46.28%
EPS Diluted -0.40 -0.40 -0.67 -0.28 -2.34 -9.75 -16.68 -46.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.